Electrostatic anti-CD33-antibody –protamine nanocarriers as platform for a targeted treatment of acute myeloid leukemia

Acute myeloid leukemia (AML) is a fatal clonal hematopoietic malignancy, which results from the accumulation of several genetic aberrations in myeloid progenitor cells, with a worldwide 5-year survival prognos...

Source: Journal of Hematology and Oncology - December 1, 2022 Category: Hematology Authors: Nicole B äumer, Annika Scheller, Lisa Wittmann, Andreas Faust, Mara Apel, Subbaiah Chary Nimmagadda, Christiane Geyer, Katharina Grunert, Neele Kellmann, Matthias Peipp, Sareetha Kailayangiri, Matias Ezequiel Gutierrez Suburu, Cristian A. Strassert, Math Tags: Research Source Type: research